尼莫样酶通过准AML中的瘤抑制剂C/EBPα来阻断髓状细胞分化
Anil Kumar Singh1,2, Gatha Thacker1, Vishal Upadhyay1,2
1Division of Cancer Biology, CSIR-Central Drug Research Institute, Lucknow, India.
The FEBS journal
|August 7, 2024
概括
尼莫样类激酶 (NLK) 酸化CCAAT/增强剂结合蛋白α (C/EBPα),导致其降解并抑制髓质分化. 向NLK恢复了C/EBPα水平,并促进了急性髓性白血病的分化.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 血液学 血液学 血液学
背景情况:
- CCAAT/增强剂结合蛋白α (C/EBPα) 是骨髓体分化的一个关键的转录因子.
- C/EBPα的失调与急性髓性白血病 (AML) 的病原发生有关.
- 了解C/EBPα的调节对于开发AML疗法至关重要.
研究的目的:
- 研究尼莫样酶 (NLK) 在调节C/EBPα.中的作用.
- 确定NLK对AML骨髓分化的影响.
- 探索NLK作为AML的潜在治疗点.
主要方法:
- 同免疫沉以评估NLK和C/EBPα之间的物理关联.
- 位点定向的突变发生,以确定C/EBPα上的酸化位点.
- 西方涂抹分析蛋白质水平和酸化状态.
- 实验室内激酶试验证实了NLK对C/EBPα.的酶活性.
- 用AML细胞系和初级患者细胞进行细胞培养实验.
主要成果:
- NLK在物理上与C/EBPα结合,并在多个位点 (Ser21, Thr226, Thr230, S234) 酸化它.
- 通过NLK的酸化导致C/EBPα无化和降解.
- NLK表达与C/EBPα蛋白水平相反相关.
- 在AML细胞和患者样本中的NLK枯竭恢复了C/EBPα水平,并诱导了髓状细胞分化.
结论:
- 通过NLK介导的C/EBPα的酸化和降解有助于AML的分化停止.
- 准NLK是一种有前途的治疗策略,可以恢复C/EBPα功能,并促进AML中的髓状细胞分化.
- 对NLK抑制的进一步研究可能会导致新的AML治疗方法.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K


